Free Trial

AnaptysBio (ANAB) News Today

AnaptysBio logo
$21.65 +0.75 (+3.59%)
As of 11:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ANAB Latest News

AnaptysBio, Inc. stock logo
Guggenheim Boosts AnaptysBio (NASDAQ:ANAB) Price Target to $90.00
Guggenheim increased their price objective on AnaptysBio from $54.00 to $90.00 and gave the company a "buy" rating in a research report on Wednesday.
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by Two Sigma Investments LP
Two Sigma Investments LP increased its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 66.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 352,034 shares of the biotechnology company's stock after acquiring an additio
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Position Lessened by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 65.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,126 shares of the b
AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Analyst Upgrade
AnaptysBio, Inc. stock logo
Two Sigma Advisers LP Boosts Position in AnaptysBio, Inc. (NASDAQ:ANAB)
Two Sigma Advisers LP raised its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 58.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 293,300 shares of the biotechnology company's stock after purchasing an additional 107,800 shares during
AnaptysBio, Inc. stock logo
Woodline Partners LP Buys 25,094 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)
Woodline Partners LP grew its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 5.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 485,073 shares of the biotechnology company's stock after purchasing
AnaptysBio, Inc. stock logo
Northern Trust Corp Boosts Position in AnaptysBio, Inc. (NASDAQ:ANAB)
Northern Trust Corp grew its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 219,986 shares of the biotechnology company's stock after buying an additional 20,073 shares dur
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Rafferty Asset Management LLC
Rafferty Asset Management LLC lifted its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 83.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,883 shares of the biotechnolog
AnaptysBio, Inc. stock logo
Frazier Life Sciences Management L.P. Reduces Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)
Frazier Life Sciences Management L.P. reduced its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 28.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,573,719 shares of the biotechnology company's stock aft
AnaptysBio, Inc. stock logo
D. E. Shaw & Co. Inc. Sells 27,030 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)
D. E. Shaw & Co. Inc. lessened its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 12.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 197,107 shares of the biotechnology company's stock after selli
AnaptysBio, Inc. stock logo
Soleus Capital Management L.P. Invests $5.48 Million in AnaptysBio, Inc. (NASDAQ:ANAB)
Soleus Capital Management L.P. purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 414,000 shares of the biotechnology company's stock, valued at approximately $5,481,000. Soleus Capital M
AnaptysBio, Inc. stock logo
Graham Capital Management L.P. Purchases Shares of 18,954 AnaptysBio, Inc. (NASDAQ:ANAB)
Graham Capital Management L.P. purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 18,954 shares of the biotechnology company's stock, valued at approximately $251,000. Graham Capital M
AnaptysBio, Inc. stock logo
Sanofi Purchases New Stake in AnaptysBio, Inc. (NASDAQ:ANAB)
Sanofi purchased a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 821,917 shares of the biotechnology company's stock, valued at approximately $10,
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Jacobs Levy Equity Management Inc.
Jacobs Levy Equity Management Inc. raised its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 85,381 shares of the biotechnology company's stock after buyi
AnaptysBio, Inc. stock logo
Dimensional Fund Advisors LP Decreases Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB)
Dimensional Fund Advisors LP lessened its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 67.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 31,608 shares of the biotechnology company's stock after selling 64,364 shares during the p
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Ensign Peak Advisors Inc
Ensign Peak Advisors Inc grew its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 184.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 215,454 shares of the biotechnology company's stock after purchasing an additional 1
AnaptysBio, Inc. stock logo
Granahan Investment Management LLC Invests $1.40 Million in AnaptysBio, Inc. (NASDAQ:ANAB)
Granahan Investment Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 106,079 shares of the biotechnology company's stock, valued at approximately $1,404,000.
AnaptysBio, Inc. stock logo
Wells Fargo & Company MN Trims Stake in AnaptysBio, Inc. (NASDAQ:ANAB)
Wells Fargo & Company MN lessened its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 59.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,120 shares of the biotechnol
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Rating of "Moderate Buy" from Analysts
AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten analysts that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued
AnaptysBio, Inc. stock logo
Bridgefront Capital LLC Makes New $252,000 Investment in AnaptysBio, Inc. (NASDAQ:ANAB)
Bridgefront Capital LLC acquired a new position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 19,011 shares of the biotechnology company's stock
AnaptysBio, Inc. stock logo
Q2 Earnings Forecast for AnaptysBio Issued By HC Wainwright
AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) - Investment analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for shares of AnaptysBio in a research report issued on Tuesday, May 6th. HC Wainwright analyst E. Bodnar now expects that the biotechnology company will earn ($1
AnaptysBio, Inc. stock logo
Leerink Partnrs Increases Earnings Estimates for AnaptysBio
AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) - Analysts at Leerink Partnrs raised their Q2 2025 earnings estimates for AnaptysBio in a research report issued to clients and investors on Tuesday, May 6th. Leerink Partnrs analyst D. Risinger now expects that the biotechnology company will post earn
AnaptysBio, Inc. stock logo
Fairmount Funds Management LLC Invests $24.05 Million in AnaptysBio, Inc. (NASDAQ:ANAB)
Fairmount Funds Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,816,466 shares of the biot
AnaptysBio, Inc. stock logo
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $54.00 at Guggenheim
Guggenheim lifted their price objective on AnaptysBio from $52.00 to $54.00 and gave the stock a "buy" rating in a research report on Tuesday.
AnaptysBio, Inc. stock logo
AnaptysBio (NASDAQ:ANAB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
AnaptysBio (NASDAQ:ANAB - Get Free Report) released its quarterly earnings data on Monday. The biotechnology company reported ($1.28) EPS for the quarter, beating the consensus estimate of ($1.30) by $0.02. AnaptysBio had a negative net margin of 289.75% and a negative return on equity of 287.94%.
AnaptysBio, Inc. stock logo
Barclays PLC Boosts Stake in AnaptysBio, Inc. (NASDAQ:ANAB)
Barclays PLC boosted its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 88.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,567 shares of the biotechnology company's
AnaptysBio, Inc. stock logo
Susquehanna Fundamental Investments LLC Takes $593,000 Position in AnaptysBio, Inc. (NASDAQ:ANAB)
Susquehanna Fundamental Investments LLC bought a new stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 44,785 shares of the biotechnology company
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Invesco Ltd.
Invesco Ltd. reduced its stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 54.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,288 shares of the biotechnology company's stock after sel
AnaptysBio, Inc. stock logo
Boxer Capital Management LLC Invests $17.21 Million in AnaptysBio, Inc. (NASDAQ:ANAB)
Boxer Capital Management LLC acquired a new stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,300,000 shares of the biotechnology company's stock, valued at approximately $17,212,000. An
AnaptysBio, Inc. stock logo
Nebula Research & Development LLC Invests $231,000 in AnaptysBio, Inc. (NASDAQ:ANAB)
Nebula Research & Development LLC acquired a new position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 17,422 shares of the biotechnology company's stock, valued at approxi
AnaptysBio, Inc. stock logo
AnaptysBio (ANAB) to Release Earnings on Thursday
AnaptysBio (NASDAQ:ANAB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-anaptysbio-inc-stock/)
AnaptysBio, Inc. stock logo
First Light Asset Management LLC Sells 79,249 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)
First Light Asset Management LLC lessened its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 868,882 shares of the biotechnology comp
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Geode Capital Management LLC
Geode Capital Management LLC boosted its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 4.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 486,597 shares of the biotechnology company's stock after acquiring an
AnaptysBio, Inc. stock logo
JPMorgan Chase & Co. Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)
JPMorgan Chase & Co. lifted its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 240.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,939 shares of the biotechnology company's stock after purchasing
Wells Fargo Sticks to Their Buy Rating for AnaptysBio (ANAB)
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by XTX Topco Ltd
XTX Topco Ltd increased its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 97.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,013 shares of the biotechnology company's stock after purchasing an additional
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. lessened its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,184 shares of the biotechnology company's stoc
AnaptysBio, Inc. stock logo
Vanguard Group Inc. Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)
Vanguard Group Inc. grew its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,843,740 shares of the biotechnology c
AnaptysBio, Inc. stock logo
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and one h
AnaptysBio, Inc. stock logo
Trexquant Investment LP Sells 37,152 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)
Trexquant Investment LP decreased its position in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 38.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 60,720 shares of the biotechnology company's stock after selling 37,152 shares during the period. Trex
AnaptysBio, Inc. stock logo
ADAR1 Capital Management LLC Reduces Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB)
ADAR1 Capital Management LLC cut its holdings in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 85.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 27,301 shares of the biotechnology company's stock after selling 165,419 shares during the peri
Leerink Partners Sticks to Its Buy Rating for AnaptysBio (ANAB)
AnaptysBio, Inc. stock logo
AnaptysBio (NASDAQ:ANAB) Trading Up 2.5% - Here's What Happened
AnaptysBio (NASDAQ:ANAB) Trading Up 2.5% - Here's What Happened
Leerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB)
Get AnaptysBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter.

ANAB Media Mentions By Week

ANAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANAB
News Sentiment

1.48

0.87

Average
Medical
News Sentiment

ANAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANAB Articles
This Week

11

5

ANAB Articles
Average Week

Get AnaptysBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ANAB) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners